scholarly journals Clinical Outcomes of Intermediate-Risk Pulmonary Embolism Across a Northeastern Health System: A Multi-Center Retrospective Cohort Study

Cureus ◽  
2021 ◽  
Author(s):  
Chuan Jiang ◽  
Meng Xie
2015 ◽  
Vol 30 (12) ◽  
pp. 1733-1740 ◽  
Author(s):  
Anna Lee D. Amarnath ◽  
Peter Franks ◽  
John A. Robbins ◽  
Guibo Xing ◽  
Joshua J. Fenton

2020 ◽  
Vol 33 (11) ◽  
pp. 1405-1416 ◽  
Author(s):  
Alessandra Agnese Grossi ◽  
Umberto Maggiore ◽  
Francesca Puoti ◽  
Paolo Antonio Grossi ◽  
Mario Picozzi ◽  
...  

2021 ◽  
Author(s):  
Sara Y. Tartof ◽  
Jeff M. Slezak ◽  
Laura Puzniak ◽  
Vennis Hong ◽  
Timothy B. Frankland ◽  
...  

Author(s):  
Ramaswamy Meenakumari ◽  
Karuppiah Thangaraj ◽  
Arunachalam Sundaram ◽  
Malayappan Meenakshi Sundaram ◽  
Ponnappan Shanmugapriya ◽  
...  

2021 ◽  
Vol 10 ◽  
pp. 204800402110310
Author(s):  
Joseph A Nardolillo ◽  
Joel C Marrs ◽  
Sarah L Anderson ◽  
Rebecca Hanratty ◽  
Joseph J Saseen

Objective To compare statin prescribing rates between intermediate-risk people living with human immunodeficiency virus (HIV; PLWH) and intermediate-risk patients without a diagnosis of HIV for primary prevention of atherosclerotic cardiovascular disease (ASCVD). Methods Retrospective cohort study . Electronic health record data were used to identify a cohort of PLWH aged 40–75 years with a calculated 10-year ASCVD risk between 7.5%-19.9% as determined by the Pooled Cohort Equation (PCE). A matched cohort of primary prevention non-HIV patients was identified. The primary outcome was the proportion of PLWH who were prescribed statin therapy compared to patients who were not living with HIV and were prescribed statin therapy Results 81 patients meeting study criteria in the PLWH cohort were matched to 81 non-HIV patients. The proportion of patients prescribed statins was 33.0% and 30.9% in the PLWH and non-HIV cohorts, respectively (p = 0.74). Conclusion and relevance: This study evaluated statin prescribing in PLWH for primary prevention of ASCVD as described in the 2018 AHA/ACC/Multisociety guideline. Rates of statin prescribing were similar, yet overall low, among intermediate-risk primary prevention PLWH compared to those not diagnosed with HIV.


Sign in / Sign up

Export Citation Format

Share Document